k succession planning: out of the box thinking for career development
TRANSCRIPT
Survey
• Q1:whohaseverappliedforagrant?• Q2:whohasNIHfunding?• Q3:whohasparticipatedinaPharma-sponsoredclinicaltrial?
• Q4:whohaseverdevelopedanyphilanthropicsupport?
4tipstograntsuccess
• BeinformedaboutRFAs• Gettoknowyourgrantsadministrator
• APPLY• Perseveretogetsomegrantfunding
Objectives• Preparingforgrantapplications• NIH• Statefunding• DOD/VA• Foundations• Pharma grants• Institutionalsupport• Philanthropy• Stayingfunded
Challengeswefacetogether
• Global/USeconomy~impactonR&D• NIHbudget~26%reductioninspendingpoweroverlast5years
• ACAwillleadtodecliningclinicalrevenuesinUSA~clinicalrevenuesstillcontribute30%toresearchatmostAMCs
• Pharma pipelinefornewdiscoveries‘empty’~mergers,reducedR&D,‘me-too’drugs
03.30.2011 9
DecliningnumbersofRO1-eq-fundedinvestigators:downby500-1,000in2013
Coincidentwith$1.55bn cutinNIHbudgetfromsequestration.ThisyearNIHbudgetUP3.5%
Why It is a Good Time to Be aJunior Investigator
• K awards program is a priority of NINDS.– Funding rates remain quite good– No strict payline ~ NINDS aims to fund about 1/3
• First R01s for early investigators are also high priority of NINDS (funding line ~25%).– Significantly higher payline than for established
investigators
Therefore a dedicated junior investigator hasa good chance of getting NINDS support forthe first 8-10 years of career.
K01MentoredResearchScientistDevelopmentAwardCareerdevelopmentinanewareaofresearch.3-5yrsPhD,MD.Noclinicalresponsibilities.
K08:MentoredClinicalScientistDevelopmentAwardDevelopmentoftheindependentclinicalresearchscientist.3-5yrs;75%effort.MD;MD,PhD
K23:MentoredPatient-OrientedResearchCareerDevelopmentAwardDevelopmentoftheindependentresearchscientistintheclinicalarena.3-5yrs,75%commitment.
MAJORKAWARDS
Early Career Development Awards • Mentored Career Awards
– K01 – Mentored Award for PhDs and MDs in new area
– K08 – Mentored Clinical Scientist Development Award
– K23 – Mentored Patient Oriented Research Career Development Award
– KL2 – Mentored award within clinical research
• Independent Career Awards– K02 – Independent Scientist Award
• Career Transition Award– K99/R00 – Pathway to Independence Award
Departmentalandinstitutionalresourcestostimulateresearchfunding
• Internalgrantreviewprocess• Officeoffacultydevelopment• Facultyadvisorsystem• Mentoring+Networking• UsingtheCTSA,BIOSetc• SharingRFAsandFoundationRFPs• Writinggroups• UsePUREtofindcollaborators
Panel Presentation:“Writing a Successful Career Development
Application” 09/25/2013 (1–2:30PM)
PANELISTS• Gaelle Kolb, PhD,
Assistant Director, PDO
REVIEWERS• George Dover, MD
Professor & Director, Pediatrics
• Greg Diette, MD, MHS Professor, Medicine
• Marsha Wills-Karp, PhD Professor & Chair, Department of Environmental Health Sciences, School of Public Health
Preparation• LookforRFAs,RFPsand
announcements~(signup)• Plantimetoprepareandsubmit.
Consideraskingforamini-sabbaticaltocompletegrant
• ReadinstructionsFULLY• Askawardeesforexamplesof
successfulgrants• Don’tforgettheLoan
RepaymentProgramsforclinicalresearchersandPhDstoo
Gettinggrants~resourcestouse
• Contactprogramofficersorfacultyonstudysection(allpublished)
• Assemble/useaninternalreviewgroup• WorkwithKtoRcommitteeinyourdepartment
• WorkwithbudgetEARLYenoughtogetsub-contractsapproved
SUGGESTEDTIME-TABLEFORGRANTSUBMISSIONS
BEGINPLANNINGGRANT6monthsbeforeduedateCOMPLETESCIENCE1-2monthsbeforeduedate
Provideto2-4expertstopre-review
COMPLETEBUDGETandFORMS1monthbeforeduedate
SubmittoORA~~~~~~~~~~~~~~~~
**Givetosomeonetoproof-read**
LASTMINUTEGRANTS…LOOKLIKELASTMINUTEGRANTS!!
New and Enhanced NIH Scoring System: What Does it Mean for Ks?
• Old scoring system: triaged grant received no score
• With the new scoring system, component scores are given from each reviewer even if grant is “ not discussed.”– Provides information regarding issues with proposal– A proposal that is not discussed may still be very
fixable and ultimately successful• Scores of 40-60 are very common in K study
sections– Keep in mind that “one moderate weakness” will
result in a 5
Kisses of Death for Ks
• Hypotheses and specific aims dependent upon success of first experiments or unproven methods.
• Undeveloped career development plan– Need courses; time-line important
• Proposals that appear not to have been read by mentor do not fare well.
Kisses of Death for Ks
• Chair letter needs to be candidate-specific and specify faculty position.– Instructor OK, assistant professor preferred
• Chair letter needs to be specific regarding clinical duties during K.
• Applications that appear rushed and unpolished, ARE rushed and unpolished
Resubmission
• If readily fixable issues were raised may be able to resubmit the next review cycle
• If significant issues are raised in the review resubmission should not be rushed!
• Mark changes (line in margin best, font change or bolding also OK) so reviewers can see what was changed.
KL2
• SeeICTR(CTSA)forlocalinstructions• 3years:2yearsofsupportfromKL2programwithinICTRand1yearfromdepartment.
• CTSAhasdevelopmentalorincubatorgrants,oftenfocusedonjuniorinvestigators
• Otherinstitutes~CFAR,NIMHHIV,Globalhealth
R21grantsNIHExploratory/DevelopmentalResearchGrantAward(R21)
TheR21grantmechanismisintendedtoencourageexploratory/developmentalresearchbyprovidingsupportfortheearlyandconceptualstagesofprojectdevelopment.• ApplicationCharacteristics
– Youmayrequestaprojectperiodofuptotwoyears– Thecombinedbudgetfordirectcostsforthetwoyearprojectperiodmaynotexceed
$275,000withnomorethan$200,000requestedinanysingleyear.– TheR21cannotberenewedandonlyoneresubmission(A1)isallowed– Nopreliminarydataarerequiredbutmaybeincludedifavailable.
• Scope:– Exploratory,novelstudiesthatbreaknewgroundorextendpreviousdiscoveriestoward
newdirectionsorapplications.– Highrisk/highrewardstudiesthatmayleadtoabreakthroughinaparticulararea,orresult
innoveltechniques,agents,methodologies,modelsorapplicationsthatwillimpactbiomedical,behavioral,orclinicalresearch.
– ProjectsshouldbedistinctfromthosesupportedthroughthetraditionalR01mechanism.
DOD/VAfunding• Disease-specificortechnology-specific• DARPAbraininjury• CongressionallyDirectedMedicalResearchPrograms(CDMRP)
Currently,theCDMRPhaseightresearchprograms:sevenfocusonresearchtocureaselectsetofdiseases,asselectedbytheU.SCongress,andtheeighthprogramfocusesonaddressingminorityandundeservedpopulations:
– BreastCancer– ProstateCancer– OvarianCancer– Neurofibromatosis– TuberousSclerosisComplex– ChronicMyelogenous Leukemia– PrionDiseases– MinorityandUnderservedPopulations
Pharma funding• Alwaysdisease-specificwithaneyetodruggabletargets
• Canfundlabresearch,BUTusuallyascontractwithharddeliverablesandtimelines
• CheckwithinstitutionforconfidentialityagreementandCOI
• Pharmatrials~secretsoffunding.– Theperpatientcostsareoftennegotiable– Don’tforgetadvertising,IRB,IDS– Roll-overunexpended$$togiftfunds– Berealisticaboutenrolment
Foundationfunding• Disease-specificfoundations,eg NMSS,AMFAR,MDA,NAF,AHA,ASA,EF
• Largeprivatefoundations,egGates,Clinton,BW,Dana,andtheAANRF(ABC)
• Smallprivatefoundations,maynotadvertisewidely,eg WWSmith,Landenberger
• Professionalgrantwritersareouttheretohelpcraftyourmessage..….
• Talktopeoplewhohavehadfunding….
FOUNDATIONS…many!Someexamples….
AmHeartAssn…$50k/yrx4AmCancerSoc…$100k/yrx5yrsAmDiabetesAssn…$80k/yrx3yrs
AmLungAssnJuvDiabetesResFnd…$160k/yrx3yrsUnitedCerebralPalsy…$50k/yrx2yrs
CysticFibrosisFndMarchofDimes….$100k/yrx3yrsSchizophreniaFnd….$100k/yrx3yrs
PfizerAward….$100k/yrx5yrs
SpecialAwardsHoodFoundation…NewEngland…$75k/yrx2yrsDonaghueFoundation…CTonly…$150k/yrx5yrs
********THESEAWARDSCANFUNDYOURPROGRAMANDPROVIDEIMPORTANTSEEDFUNDS
APPLY…APPLY…APPLYSENDSIMILARAPPLICATIONTOSEVERALFOUNDATIONS
Howtofindfoundations
• Institutionalresources~OfficeofResourceAdministration
• Seewhotheyfundedinthepast• Findoutwhoisontheirscientificreviewboard
http://www.findit.org/html/fund_online_foundations.html
Philanthropy
• It’sALLabouttherelationship• Listenforinterest:“tellmeaboutyourresearch”,
OR“whatcanIdotogetinvolved”• Maketimetotalk,andhavematerialsreadyto
deliver• Involvedevelopment…theywillhaveanideaof
“capacity”andstrategy,andhelpyouavoidpratfalls
Othersourcesoffunding
• Inventions/licensing/commercial– Officeoftechnologylicensing– Distributionof$faculty/university
– Spin-offcompanies– Clinicallabs(CLIA-approved)
• Regulation/marketing/billing
10/13/16 jcm 86
Stayingfunded
• SeekRFPs,newopportunitiesforfunding• NIHworkshopsareoftenapreludetoRFPs• Stewardshipofprogramofficer,donor,highlightproductivity,pressreleases
• BeawareofyourbudgetsandbeupfrontwithChairforfundinggaps.
• Behonestwithyourstaff,andseektheirhelpfordeadlinesorrecruitment
4tipstograntsuccess
• BeinformedaboutRFAs• Gettoknowyourgrantsadministrator
• APPLY• Perseveretogetsomegrantfunding